相关实验视频
Updated: May 2, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.9K
Rbm39通过调节Apob和Fabp4来改善与代谢功能障碍相关的脂肪性肝病
Chunbo Zhuang1, Fangfang Cui2, Jin Chen1
1Department of Clinical Laboratory, Key Clinical Laboratory of Henan Province, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, PR China.
Biochimica et biophysica acta. Molecular basis of disease
|March 27, 2025
概括
RNA结合动机蛋白39 (Rbm39) 在与代谢功能障碍相关的脂肪性肝病 (MASLD) 中对肝脏健康至关重要. 降低Rbm39会使MASLD恶化,而增加它会改善肝脏脂肪积累和脂质水平.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 具有过度的肝脂肪积累的特征.
- 驱动MASLD进展的精确分子机制仍然不完全理解.
- 鉴定肝脂平衡的关键调节者对于治疗的发展至关重要.
研究的目的:
- 调查RNA结合基因蛋白39 (Rbm39) 在MASLD期间调节肝脂质平衡中的作用.
- 阐明Rbm39影响MASLD发育和进展的分子机制.
主要方法:
- 在小鼠中使用高脂肪 (HFD) 和Gubra-Amylin NASH (GAN) 饮食建立了体内MASLD模型.
- 利用腺相关病毒 (AAV) 载体来操纵肝脏Rbm39表达.
- 进行了转录组分析 (RNA测序),西部抹迹,RT-PCR,双化酶记者测定和替代拼接分析.
主要成果:
- 在MASLD模型小鼠的肝脏中,Rbm39的表达显著下降.
- 肝脏Rbm39 knockdown加剧了饮食引起的肝肥胖症和MASH,降低了血清脂质水平.
- 过度表达Rbm39减弱了MASLD的发展和进展.
- 发现Rbm39可以调节阿波蛋白B (Apob) 和脂肪酸结合蛋白4 (Fabp4) 的表达.
结论:
- Rbm39在维持肝脂质平衡中发挥着关键作用.
- Rbm39通过涉及Hnf4α和Hif-1α拼接的独特分子机制调节Apob和Fabp4的表达.
- Rbm39代表了MASLD的潜在治疗点.
相关概念视频
02:23RNA Editing
8.3K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.3K
01:30Liver Physiology
3.8K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.8K
01:24Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K